Industry Supported Session
This session will raise awareness about the evolving role of registries in optimizing care in SMA in Canada and internationally. Disease registries are increasingly recognized as important repositories for real world evidence that can inform the management of patients – particularly those with rare diseases such as spinal muscular atrophy. This course will provide an overview of how registries have played an instrumental role in informing new clinical standards in other areas and explore opportunities for implementation in Canada.
This program was developed by the CNSF and Novartis Pharmaceuticals Canada and was planned to achieve scientific integrity, objectivity and balance. It is an unaccredited learning activity and not eligible for MOC credits.
Speaker: Hanns Lochmuller
Speaker: Megan Crone
Faculty: Kathryn Selby
Speaker: Hanns Lochmuller
Speaker: Megan Crone
Speaker: Hanns Lochmuller